Publicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (19)

2024

  1. Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis

    Leukemia

  2. Improvement of Early Outcomes in Type A Acute Aortic Syndrome After an Aorta Code Implementation

    Annals of Thoracic Surgery, Vol. 117, Núm. 4, pp. 770-778

  3. The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis

    American Journal of Hematology

2023

  1. Tuberculosis in Spain: An opinion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583

2021

  1. Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E23-E28

2019

  1. Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia

    Human Mutation, Vol. 40, Núm. 8, pp. 1181-1190

2018

  1. Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes

    Archivos de Bronconeumologia, Vol. 54, Núm. 11, pp. 559-567

  2. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis

    Respiration, Vol. 96, Núm. 5, pp. 406-416

  3. Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study

    Archivos de Bronconeumologia, Vol. 54, Núm. 5, pp. 270-279

2017

  1. Clinical audit of COPD in outpatient respiratory clinics in Spain: The EPOCONSUL study

    International Journal of COPD, Vol. 12, pp. 417-426

  2. The variability of respiratory symptoms and associated factors in COPD

    Respiratory Medicine, Vol. 129, pp. 165-172

2016

  1. Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia

    Leukemia Research, Vol. 40, pp. 1-9

  2. Perfil clínico y mortalidad a 90 días de los pacientes centenarios atendidos en servicios de urgencias hospitalarios

    Revista Espanola de Geriatria y Gerontologia, Vol. 51, Núm. 4, pp. 196-200

2010

  1. Study of Prevalence and Attitudes on Smoking in Patients on Continuous Home Oxygen Therapy. Toma Study

    Archivos de Bronconeumologia, Vol. 46, Núm. 11, pp. 580-586

  2. Tabaquismo

    Revista de Patologia Respiratoria, Vol. 13, Núm. 2, pp. 97-99

2008

  1. Efecto de AM3 en la calidad de vida de pacientes con enfermedad pulmonar obstructiva crónica en subgrupos de riesgo

    Medicina Clinica, Vol. 130, Núm. 18, pp. 688-692

2006

  1. Treatment with AM3 restores defective T-cell function in COPD patients

    Chest, Vol. 129, Núm. 3, pp. 527-535

2004

  1. Efecto del inmunomodulador AM3 sobre las agudizaciones en enfermos con bronquitis crónica: Una revisión sistemática de estudios controlados

    Revista Clinica Espanola, Vol. 204, Núm. 9, pp. 466-471

2001

  1. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferón)

    American Journal of Respiratory and Critical Care Medicine, Vol. 163, Núm. 7, pp. 1578-1583